Revenue, last quarter
$115K
−16.1% vs same quarter last year
Net income
−$6.1M
+15% vs same quarter last year
EPS, diluted
−$1.91
+51.4% vs same quarter last year
Operating cash flow
−$2.7M
+46.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.2M | −$22.7M |
| FY24 | $2.4M | −$16M |
| FY23 | $709K | −$21.4M |
| FY22 | $1.2M | −$18.8M |
| FY21 | $1.3M | −$17M |
| FY20 | $5.6M | −$3.7M |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 67% | −1942.2% | −1893.6% |
| FY24 | 78.8% | −690.7% | −667.8% |
| FY23 | 31.2% | −2966% | −3020.2% |
| FY22 | 40.7% | −1476.5% | −1541.3% |
| FY21 | 45.2% | −1336.6% | −1305.1% |
| FY20 | 32.4% | −67.1% | −66.1% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$18.9M |
| FY24 | −$14.5M |
| FY23 | −$19.3M |
| FY22 | −$14.5M |
| FY21 | −$10M |
| FY20 | −$2.5M |
| FY19 | - |
- Longeveron
- Healthcare median
Show the numbers
| Year | Longeveron | Healthcare median |
|---|---|---|
| FY25 | −1893.6% | −30.6% |
| FY24 | −667.8% | −47% |
| FY23 | −3020.2% | −58% |
| FY22 | −1541.3% | −80.4% |
| FY21 | −1305.1% | −71.8% |
| FY20 | −66.1% | −62.2% |
| FY19 | - | −46.2% |